CPAMD8 and DPP4

Number of citations of the paper that reports this interaction (PMID 11696365)
11

Data Source:
HPRD (in vitro)

		CPAMD8	DPP4
Gene Name		C3 and PZP-like, alpha-2-macroglobulin domain containing 8	dipeptidyl-peptidase 4
Image		No pdb structure
Gene Ontology Annotations	Cellular Component	Extracellular Space Plasma Membrane	Lysosomal Membrane Plasma Membrane Focal Adhesion Cell Surface Membrane Integral Component Of Membrane Apical Plasma Membrane Lamellipodium Endocytic Vesicle Lamellipodium Membrane Membrane Raft Intercellular Canaliculus Extracellular Vesicular Exosome Invadopodium Membrane
	Molecular Function	Serine-type Endopeptidase Inhibitor Activity	Protease Binding Serine-type Endopeptidase Activity Receptor Binding Protein Binding Serine-type Peptidase Activity Dipeptidyl-peptidase Activity Identical Protein Binding Protein Homodimerization Activity
	Biological Process	Negative Regulation Of Endopeptidase Activity	Response To Hypoxia Proteolysis Positive Regulation Of Cell Proliferation Negative Regulation Of Extracellular Matrix Disassembly T Cell Costimulation Regulation Of Cell-cell Adhesion Mediated By Integrin T Cell Activation Endothelial Cell Migration
Pathways			Peptide hormone metabolism Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) Incretin synthesis, secretion, and inactivation
Drugs			Atorvastatin Sitagliptin 2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One 5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine Alpha-D-Mannose (2s)-Pyrrolidin-2-Ylmethylamine Iodo-Phenylalanine Diisopropylphosphono Group 1-(1-phenylcyclopentyl)methylamine (S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide Vildagliptin Alogliptin Saxagliptin (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE (2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine (2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine (7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c\']dipyridin-7-amine (2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE (1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE (2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE (2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE (2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE (3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE 4\'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide (2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine 7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile (3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-(2,2,2-TRIFLUOROETHYL)-1,4-DIAZEPAN-2-ONE METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE 1-biphenyl-2-ylmethanamine (1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile (2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE (3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE (4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE (3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE 1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE (1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE (2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE (3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE 2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide (3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE 6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM 7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE 2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE 4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE 2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE Linagliptin
Diseases
GWAS		Brain lesion load ( 19010793) Crohn's disease ( 22412388)	Hippocampal volume ( 22504421)
Protein-Protein Interactions		3 interactors: ADCYAP1 DPP4 SCTR	16 interactors: ADA CCL11 CCL22 CCL3L1 CCL5 CD4 CPAMD8 CXCL10 CXCL11 CXCL12 CXCL9 CXCR4 DKK1 FAP GRP PTPRC
Entrez ID		27151	1803
HPRD ID		09892	02187
Ensembl ID		ENSG00000160111	ENSG00000197635
Uniprot IDs		Q6NVW5 Q8IZJ3	P27487
PDB IDs			1J2E 1N1M 1NU6 1NU8 1PFQ 1R9M 1R9N 1RWQ 1TK3 1TKR 1U8E 1W1I 1WCY 1X70 2AJL 2BGN 2BGR 2BUB 2FJP 2G5P 2G5T 2G63 2HHA 2I03 2I78 2IIT 2IIV 2JID 2OAG 2OGZ 2OLE 2ONC 2OPH 2OQI 2OQV 2P8S 2QJR 2QKY 2QOE 2QT9 2QTB 2RGU 2RIP 3BJM 3C43 3C45 3CCB 3CCC 3D4L 3EIO 3F8S 3G0B 3G0C 3G0D 3G0G 3H0C 3HAB 3HAC 3KWF 3KWJ 3NOX 3O95 3O9V 3OC0 3OPM 3Q0T 3Q8W 3QBJ 3SWW 3SX4 3VJK 3VJL 3VJM 3W2T 4A5S 4DSA 4DSZ 4DTC 4G1F 4JH0 4KR0 4L72 4LKO
Enriched GO Terms of Interacting Partners?		Positive Regulation Of Somatostatin Secretion Negative Regulation Of Acute Inflammatory Response To Non-antigenic Stimulus Negative Regulation Of Extracellular Matrix Organization Negative Regulation Of Extracellular Matrix Disassembly Negative Regulation Of Acute Inflammatory Response To Antigenic Stimulus Positive Regulation Of Adenylate Cyclase Activity Involved In G-protein Coupled Receptor Signaling Pathway Regulation Of Adenylate Cyclase Activity Involved In G-protein Coupled Receptor Signaling Pathway Positive Regulation Of Growth Hormone Secretion Regulation Of Cell-cell Adhesion Mediated By Integrin Regulation Of Oligodendrocyte Progenitor Proliferation Regulation Of Growth Hormone Secretion Negative Regulation Of Glial Cell Proliferation Negative Regulation Of Inflammatory Response To Antigenic Stimulus Negative Regulation Of Rho GTPase Activity Negative Regulation Of Acute Inflammatory Response Histamine Secretion Positive Regulation Of Rap GTPase Activity Histamine Transport Negative Regulation Of Ras GTPase Activity Regulation Of Rap GTPase Activity CAMP-mediated Signaling Negative Regulation Of Potassium Ion Transport Positive Regulation Of Synaptic Transmission, Glutamatergic Regulation Of Rap Protein Signal Transduction Positive Regulation Of Cell Proliferation Activation Of Adenylate Cyclase Activity Cyclic-nucleotide-mediated Signaling Regulation Of Extracellular Matrix Disassembly Positive Regulation Of Vasodilation Negative Regulation Of GTPase Activity Negative Regulation Of Muscle Cell Apoptotic Process Positive Regulation Of Adenylate Cyclase Activity Behavioral Fear Response Regulation Of Extracellular Matrix Organization Fear Response Regulation Of Cell Adhesion Mediated By Integrin Regulation Of Vasodilation Excretion Positive Regulation Of Lyase Activity Cellular Response To Glucocorticoid Stimulus Cellular Response To Corticosteroid Stimulus Adenylate Cyclase-activating G-protein Coupled Receptor Signaling Pathway G-protein Coupled Receptor Signaling Pathway Regulation Of Muscle Cell Apoptotic Process Pituitary Gland Development Regulation Of Adenylate Cyclase Activity	Cell Chemotaxis Cell Migration Locomotion Chemotaxis Cell Motility Chemokine-mediated Signaling Pathway Response To Virus Response To Other Organism Response To Biotic Stimulus Regulation Of Behavior Regulation Of Cell Migration Leukocyte Chemotaxis Response To External Stimulus Regulation Of Cell Motility Regulation Of Leukocyte Migration Inflammatory Response Regulation Of Locomotion Regulation Of Cellular Component Movement Movement Of Cell Or Subcellular Component Regulation Of Chemotaxis Immune System Process Positive Regulation Of Leukocyte Chemotaxis Positive Regulation Of Cell Migration Positive Regulation Of Cell Motility Immune Response Positive Regulation Of Cellular Component Movement Positive Regulation Of Locomotion Defense Response Positive Regulation Of Leukocyte Migration Positive Regulation Of Calcium Ion Transport Regulation Of Cell Proliferation Leukocyte Migration Positive Regulation Of Chemotaxis Positive Regulation Of Behavior Positive Regulation Of Intracellular Signal Transduction T Cell Chemotaxis Regulation Of Intracellular Signal Transduction Leukocyte Cell-cell Adhesion Positive Regulation Of Immune System Process Response To Stress Positive Regulation Of CAMP-mediated Signaling Regulation Of Calcium Ion Transport Regulation Of Signal Transduction Positive Regulation Of Ion Transport Lymphocyte Chemotaxis Response To Cytokine T Cell Migration Positive Regulation Of T Cell Migration Cytokine-mediated Signaling Pathway Regulation Of T Cell Migration
Tagcloud ?			albuminuria ameliorate bioavailability capability dipeptidyl english experimentally glp indirectly insufficient interfere journals language march microalbuminuria microangiopathy microvascular modifying nephropathy neuropathy nonincretin peer peptidase preliminary retinopathy retrieved scanned ulcer
Tagcloud (Difference) ?			albuminuria ameliorate bioavailability capability dipeptidyl english experimentally glp indirectly insufficient interfere journals language march microalbuminuria microangiopathy microvascular modifying nephropathy neuropathy nonincretin peer peptidase preliminary retinopathy retrieved scanned ulcer
Tagcloud (Intersection) ?